CDKN2A and urinary bladder cancer: Deletions and mutations of the INK4 genes also occur frequently in Ta/T1 bladder cancer, although only deletions affecting both p16 and p19, deregulating both the pRB and p53 pathways, correlate with a worse prognosis [95].